Multiple HLA Epitopes Contribute to Type 1 Diabetes Susceptibility
- Christina L. Roark1⇑,
- Kirsten M. Anderson2,
- Lucas J. Simon1,
- Ronald P. Schuyler3,
- Michael T. Aubrey1 and
- Brian M. Freed1,2
- 1ClinImmune Labs and Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO
- 2Department of Immunology, University of Colorado Anschutz Medical Campus, Aurora, CO
- 3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO
- Corresponding author: Christina L. Roark, .
Disease susceptibility for type 1 diabetes is strongly associated with the inheritance of specific HLA alleles. However, conventional allele frequency analysis can miss HLA associations because many alleles are rare. In addition, disparate alleles that have similar peptide-binding sites, or shared epitopes, can be missed. To identify the HLA shared epitopes associated with diabetes, we analyzed high-resolution genotyping for class I and class II loci. The HLA epitopes most strongly associated with susceptibility for disease were DQB1 A57, DQA1 V76, DRB1 H13, and DRB1 K71, whereas DPB1 YD9,57, HLA-B C67, and HLA-C YY9,116 were more weakly associated. The HLA epitopes strongly associated with resistance were DQB1 D57, DQA1 Y80, DRB1 R13, and DRB1 A71. A dominant resistance phenotype was observed for individuals bearing a protective HLA epitope, even in the presence of a susceptibility epitope. In addition, an earlier age of disease onset correlated with significantly greater numbers of susceptibility epitopes and fewer resistance epitopes (P < 0.0001). The prevalence of both DQ and DR susceptibility epitopes was higher in patients than in control subjects and was not exclusively a result of linkage disequilibrium, suggesting that multiple HLA epitopes may work together to increase the risk of developing diabetes.
This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db13-1153/-/DC1.
This manuscript was not prepared in collaboration with investigators of the T1DGC study and does not necessarily reflect the opinions or views of the T1DGC study, the NIDDK Central Repositories, or the study sponsors.
- Received July 25, 2013.
- Accepted September 10, 2013.
- © 2014 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.